Back to Qube Research & Technologies Ltd Qube Research & Technologies Ltd

MLTXMLTX
Showing 2 of 5 quarters

Position history for Qube Research & Technologies LtdQube Research & Technologies Ltd's holdings in MoonLake Immunotherapeutics Class A

Qube Research & Technologies Ltd holds 496,242 shares of MLTX (MoonLake Immunotherapeutics Class A), worth $9.7M as of 2026-Q2. The position was increased (+1056.3% shares). MLTX represents 0.0% of Qube Research & Technologies Ltd's portfolio.

Current Value

$9.7M

Current Shares

496,242

Total Value Change

+$8.9M

Total Shares Change

+453,325

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2026-Q2
Latest
Increased
496,242
+1056.3%
$9.7M0.0%$19.47
45
2026-Q1
New
42,917
-
$799,9730.0%$17.69
34

Other major holders of MLTX: FMR LLC, Avoro Capital Advisors LLC, PRICE T ROWE ASSOCIATES INC /MD/

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used